Lineage Cell Therapeutics, Inc. (LCTX) shows vision gains in the Orengen test of phase 1/2a
In this article, we will take a look at 15 best biotechnology actions to invest at this time. Lineage Cell Therapeutics, Inc. is one of them. Lineage Cell Therapeutics, Inc. (NYSE: LCTX) is a clinical stage biotechnology company that develops alogenic cell therapies “ready to use” for neurological and ophthalmic disorders. Its patented platform engineer…